Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.

Oncotarget - 5 Jul 2016

Kim Ye Sol, Park Sae Jeong, Lee Yeon Seon, Kong Hyun Kyung, Park Jong Hoon

Abstract excerpt

Estrogen receptor-alpha (ERα) is a clinically important therapeutic target for breast cancer. However, tumors that lose ERα are less responsive to anti-estrogens such as tamoxifen. MicroRNAs (miRNAs) are small RNAs that regulate expression of their target gene and dysregulations of miRNA has been identified in many diseases including human cancer. However, only a few miRNAs associated with tamoxifen resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Antigens, Ly
Share to Cell Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Receptor alpha

Share to GPI-Linked Proteins

Share to MCF-7 Cells

Share to RNA, Small Interfering

Share to Tamoxifen

Source

Open in PubMed Open full text

Identifiers

PMID: 27304060
DOI: 10.18632/oncotarget.9950
PMCID: PMC5173133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.PMID 27304060Read ↗

let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast CancerSemantic proximity Read ↗

Metastatic effect of LY-6K gene in breast cancer cellsSemantic proximity Read ↗

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapySemantic proximity Read ↗

Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.Semantic proximity Read ↗

The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progressionSemantic proximity Read ↗

miR-489 Confines Uncontrolled Estrogen Signaling Through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast CancerSemantic proximity Read ↗

MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ Breast CancerSemantic proximity Read ↗

LGR6 Promotes Tumor Proliferation and Metastasis through Wnt/β-Catenin Signaling in Triple-Negative Breast CancerSemantic proximity Read ↗

KLK6‐regulated miRNA networks activate oncogenic pathways in breast cancer subtypesSemantic proximity Read ↗

LncRNA-42060 Regulates Tamoxifen Sensitivity and Tumor Development via Regulating the miR-204-5p/SOX4 Axis in Canine Mammary Gland Tumor CellsSemantic proximity Read ↗

Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanismSemantic proximity Read ↗

ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.